News

News Releases

Recent news releases

Month Year

Month Year

Investor Alerts

Jul 16, 2026

Apotex Receives Investment Grade Issuer Rating from Morningstar DBRS and Announces Amended & Restated Credit Agreement
Jul 9, 2026

Apotex to Announce First Quarter Fiscal 2027 Financial Results and Host Conference Call on August 12, 2026
Jul 8, 2026

Apotex expands U.S. hospital portfolio with launch of generic Infuvite® Adult and Pediatric Injection
Jul 1, 2026

Apotex Completes Previously Announced Strategic Transaction with Cumberland Pharmaceuticals
Jun 30, 2026

Apotex first to receive Health Canada approval for SEVMIA™, a generic semaglutide for chronic weight management

Show per page